HeartSciences Inc. (HSCS) Revenue (2021 - 2025)

HeartSciences (HSCS) has reported Revenue for 5 consecutive years, with $2419.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Revenue changed N/A year-over-year to $2419.0; the trailing twelve-month figure through Apr 2026 stood at $8669.0 (down 54.49% YoY), and the FY2026 full-year result was $4319.0, down 0.71% from the prior year.
• Revenue rose to $2419.0 in Q4 2025 per HSCS's latest filing, from $1900.0 in the prior quarter.
• Across five years, Revenue topped out at $14700.0 in Q1 2024 and bottomed at $1900.0 in Q3 2025.
• Historically, Revenue has averaged $4679.2 across 5 years, with a median of $3550.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Revenue tumbled 57.24% in 2022, then soared 653.85% in 2024.
• Over 5 years, Revenue stood at $7484.0 in 2021, then sank by 57.24% to $3200.0 in 2022, then increased by 21.88% to $3900.0 in 2023, then surged by 276.92% to $14700.0 in 2024, then plunged by 83.54% to $2419.0 in 2025.
• According to Business Quant data, Revenue over the past three periods registered $2419.0, $1900.0, and $4350.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.